JP2025504398A5 - - Google Patents

Info

Publication number
JP2025504398A5
JP2025504398A5 JP2024541179A JP2024541179A JP2025504398A5 JP 2025504398 A5 JP2025504398 A5 JP 2025504398A5 JP 2024541179 A JP2024541179 A JP 2024541179A JP 2024541179 A JP2024541179 A JP 2024541179A JP 2025504398 A5 JP2025504398 A5 JP 2025504398A5
Authority
JP
Japan
Prior art keywords
seq
cancer
sequence
nos
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024541179A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025504398A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/010518 external-priority patent/WO2023133358A2/en
Publication of JP2025504398A publication Critical patent/JP2025504398A/ja
Publication of JP2025504398A5 publication Critical patent/JP2025504398A5/ja
Pending legal-status Critical Current

Links

JP2024541179A 2022-01-10 2023-01-10 Muc16キメラ抗原受容体 Pending JP2025504398A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263298141P 2022-01-10 2022-01-10
US63/298,141 2022-01-10
PCT/US2023/010518 WO2023133358A2 (en) 2022-01-10 2023-01-10 Muc16 chimeric antigen receptors

Publications (2)

Publication Number Publication Date
JP2025504398A JP2025504398A (ja) 2025-02-12
JP2025504398A5 true JP2025504398A5 (https=) 2026-01-16

Family

ID=87074219

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024541179A Pending JP2025504398A (ja) 2022-01-10 2023-01-10 Muc16キメラ抗原受容体

Country Status (12)

Country Link
US (1) US20250082756A1 (https=)
EP (1) EP4463471A4 (https=)
JP (1) JP2025504398A (https=)
KR (1) KR20240159826A (https=)
CN (1) CN118829652A (https=)
AU (1) AU2023205776A1 (https=)
CA (1) CA3246886A1 (https=)
CL (1) CL2024002066A1 (https=)
CO (1) CO2024010826A2 (https=)
IL (1) IL314076A (https=)
MX (1) MX2024008615A (https=)
WO (1) WO2023133358A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116814664B (zh) * 2023-08-25 2023-12-12 中国医学科学院肿瘤医院 一种扩展肿瘤识别表位的cea嵌合抗原受体t细胞的制备与应用
CN117866070A (zh) * 2023-12-11 2024-04-12 山东省农业科学院家禽研究所(山东省无特定病原鸡研究中心) 一种抗新城疫病毒card11蛋白突变体、构建及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3134432T3 (pl) * 2014-04-25 2020-10-19 Bluebird Bio, Inc. Promotor mnd chimeryczne receptory antygenowe
JP7066690B2 (ja) * 2016-09-23 2022-05-13 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 抗muc16(ムチン16)抗体
US20220362295A1 (en) * 2019-04-22 2022-11-17 TCR2 Therapeutics Inc. Compositions and methods for tcr reprogramming using fusion proteins
US11026973B2 (en) * 2019-04-30 2021-06-08 Myeloid Therapeutics, Inc. Engineered phagocytic receptor compositions and methods of use thereof

Similar Documents

Publication Publication Date Title
JP7741732B2 (ja) Bcmaを標的とする操作された免疫細胞及びその使用
CN113784733B (zh) 靶向bcma的工程化免疫细胞及其用途
RU2016145958A (ru) Химерные антигенные рецепторы с mnd-промотором
JP2022513460A5 (https=)
CN108884164B (zh) 用于免疫疗法的经修饰细胞
EP4219693A1 (en) Chimeric antigen receptor targeting cd7 and use thereof
RU2017106025A (ru) Химерные антигенные рецепторы к bcma
JP2020500530A5 (https=)
JP2018526028A5 (https=)
JP2021519580A5 (https=)
JP2021532742A5 (https=)
JP2017522882A5 (https=)
WO2017176525A1 (en) Car having replicated binding motifs in a co-stimulatory domain
JP2017538710A5 (https=)
JP2025504398A5 (https=)
JP2021527409A5 (https=)
JP2015513920A5 (https=)
JP2021514631A5 (https=)
RU2017130985A (ru) Фармацевтическая композиция и способ снижения ингибирующего эффекта pd-l1 на т-клетки человека
JP2019518425A5 (https=)
JP2023539591A5 (https=)
JP2018521628A5 (https=)
US20240082306A1 (en) Novel chimeric antigen receptor and use thereof
JP2024534471A5 (https=)
JP2023522038A5 (https=)